This federal contract indefinite delivery vehicle (IDV) award, with ID 36F79721D0073, is a General Services Administration (GSA) Federal Supply Schedule 65-VII contract for in vitro diagnostics, reagents, and test kits held by Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract, valued at up to $300 million, was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to support COVID-19 testing and diagnostic needs across its integrated service networks.
Under this IDV, Abbott Rapid DX North America LLC has received numerous delivery orders from various VA regional networks to provide BinaxNOW COVID-19 antigen test kits, reagents, and other diagnostic supplies. These firm fixed price awards, valued from hundreds to over $400,000, have supported ongoing testing programs at VA medical facilities, particularly in Florida. Abbott Laboratories also holds several Blanket Purchase Agreements under this GSA Schedule contract, valued up to $5.2 million, to streamline procurement of COVID-19 tests and supplies for the VA. The contracted products and services aim to enable timely medical screening, diagnosis, and treatment of veterans during the public health emergency.
Generated 2/6/25, 9:05 AM